
Cardiology Insights from Payal Kohli, MD, FACC
DocWire News medical lead Payal Kohli, MD, FACC, is a noninvasive cardiologist and managing partner of Cherry Creek Heart in Denver, Colorado. Her clinical interests are in preventive cardiology, echocardiography and heart disease in women. She has spoken and presented internationally on cardiovascular clinical research, and has published work in leading journals, including JAMA, Lancet, Circulation, and JACC.
Dr. Kohli highlights the benefits of early, sustained LDL lowering for greater cardiovascular risk reduction and prevention.
Non-statin therapies key for high-risk patients not at LDL goal, says Dr. Kohli; advocates broader risk assessment.
CKM syndrome redefines heart disease risk—90% of adults may already be affected. Learn why this new staging system matters.
Dr. Payal Kohli dives into new tech and AI reshaping how we diagnose and manage hypertension.
Hypertension isn’t just a part of aging—lifestyle, awareness, and new treatments matter.
Dr. Kohli discusses the SELECT trial, which showed that semaglutide can benefit obese patients with heart disease.
Cardio Care Today delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from Cardio Care Today experts, including Dr. Kohli.